These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy. Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24 Minami T; Matsumura N; Sugimoto K; Shimizu N; De Velasco M; Nozawa M; Yoshimura K; Harashima N; Harada M; Uemura H Int Immunopharmacol; 2017 Mar; 44():197-202. PubMed ID: 28110220 [TBL] [Abstract][Full Text] [Related]
10. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment. Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707 [TBL] [Abstract][Full Text] [Related]
11. Identification of Hypoxia-ALCAM Xun Z; Zhou H; Shen M; Liu Y; Sun C; Du Y; Jiang Z; Yang L; Zhang Q; Lin C; Hu Q; Ye Y; Han L Adv Sci (Weinh); 2024 Sep; 11(33):e2309885. PubMed ID: 38956900 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Doedens AL; Phan AT; Stradner MH; Fujimoto JK; Nguyen JV; Yang E; Johnson RS; Goldrath AW Nat Immunol; 2013 Nov; 14(11):1173-82. PubMed ID: 24076634 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic HIF stabilization activates costimulatory receptor expression to increase antitumor efficacy of adoptive T cell therapy. Walter Jackson Iii ; Yang Y; Salman S; Dordai D; Lyu Y; Datan E; Drehmer D; Huang TY; Hwang Y; Semenza GL Sci Adv; 2024 Aug; 10(35):eadq2366. PubMed ID: 39196939 [TBL] [Abstract][Full Text] [Related]
14. A Kjaergaard J; Hatfield S; Jones G; Ohta A; Sitkovsky M J Immunol; 2018 Jul; 201(2):782-791. PubMed ID: 29802128 [TBL] [Abstract][Full Text] [Related]
15. Gramicidin A blocks tumor growth and angiogenesis through inhibition of hypoxia-inducible factor in renal cell carcinoma. David JM; Owens TA; Inge LJ; Bremner RM; Rajasekaran AK Mol Cancer Ther; 2014 Apr; 13(4):788-99. PubMed ID: 24493697 [TBL] [Abstract][Full Text] [Related]
17. Enhanced HIF2α expression during human trophoblast differentiation into syncytiotrophoblast suppresses transcription of placental growth factor. Fujii T; Nagamatsu T; Morita K; Schust DJ; Iriyama T; Komatsu A; Osuga Y; Fujii T Sci Rep; 2017 Sep; 7(1):12455. PubMed ID: 28963486 [TBL] [Abstract][Full Text] [Related]
18. Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development. Steunou AL; Ducoux-Petit M; Lazar I; Monsarrat B; Erard M; Muller C; Clottes E; Burlet-Schiltz O; Nieto L Mol Cell Proteomics; 2013 Mar; 12(3):736-48. PubMed ID: 23275444 [TBL] [Abstract][Full Text] [Related]
19. Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy. Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW Gene Ther; 2001 Apr; 8(8):638-45. PubMed ID: 11320410 [TBL] [Abstract][Full Text] [Related]
20. Differential Contribution of N- and C-Terminal Regions of HIF1α and HIF2α to Their Target Gene Selectivity. Bouthelier A; Meléndez-Rodríguez F; Urrutia AA; Aragonés J Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]